Anti‐inflammatory drugs as risk modifiers for Alzheimer’s disease: a step towards precision prevention
This study supports the association between aIT and a reduced risk of AD. Key factors influencing this relationship included patient age, treatment duration, and the drug class used. These nuanced findings can guide future interventions targeting neuroinflammation in AD prevention.
Authors
- Georgina Torrandell‐Haro (ORCID: https://orcid.org/0000-0003-2872-8282)
- Helena Cortes‐Flores
- Roberta Diaz Brinton
Institutions
- University of Arizona (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_106694
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00